» Articles » PMID: 2107627

Immunohistochemical Study of the Abnormal Cells in Langerhans Cell Histiocytosis (histiocytosis X)

Overview
Date 1990 Jan 1
PMID 2107627
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The immunophenotypic properties of the abnormal cells in routine specimens from 16 cases of Langerhans cell histiocytosis (LCH) were examined. In five cases, cryostat sections were also available. The abnormal cells expressed a similar phenotype and were positive for HLA-DR, S-100 protein, peanut agglutinin (PNA), CD1a, CD4 and several macrophage-associated markers, including CD11c, CDw32 and CD68 (the latter detectable in routine sections with antibody KP1). Staining with CD14, CD35 (C3b receptor), and CD11b (C3bi receptor) was negative with the exception of one of the cases in which a proportion of the cells showed faint positivity with CD11b. Staining for pan-T-cell (CD2, CD3, CD5) and pan-B-cell (CD19, CD22) antigens was negative in all lesions. It is concluded that LCH expresses a characteristic phenotype with some heterogeneity with regard to macrophage markers and that immunohistochemical methods in cryostat sections and routine specimens form a useful supplement to other techniques for the diagnosis of this condition.

Citing Articles

Langerhans Cell Histiocytosis Shows Distinct Cytoplasmic Expression of Major Histocompatibility Class II Antigens.

Redd L, Schmelz M, Burack W, Cook J, Day A, Rimsza L J Hematop. 2018; 9(3):107-112.

PMID: 30338008 PMC: 6191044. DOI: 10.1007/s12308-016-0272-9.


Neither IL-17A mRNA nor IL-17A protein are detectable in Langerhans cell histiocytosis lesions.

Peters T, McClain K, Allen C Mol Ther. 2011; 19(8):1433-9.

PMID: 21654633 PMC: 3149162. DOI: 10.1038/mt.2011.106.


Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells.

Allen C, Li L, Peters T, Leung H, Yu A, Man T J Immunol. 2010; 184(8):4557-67.

PMID: 20220088 PMC: 3142675. DOI: 10.4049/jimmunol.0902336.


Differential Expression of Markers in Extensive and Restricted Langerhans Cell Histiocytosis (LCH).

Kohalmi F, Strausz J, Egervary M, Szekeres G, Timar J Pathol Oncol Res. 1996; 2(3):184-187.

PMID: 11173605 DOI: 10.1007/BF02903525.


Expression of the monoclonal antibody HECA-452 defined E-selectin ligands in Langerhans cell histiocytosis.

Simonitsch I, Kopp C, Mosberger I, Volc-Platzer B, Radaszkiewicz T Virchows Arch. 1996; 427(5):477-81.

PMID: 8624576 DOI: 10.1007/BF00199507.


References
1.
Hall P, ODoherty C, Levison D . Langerhans cell histiocytosis: an unusual case illustrating the value of immunohistochemistry in diagnosis. Histopathology. 1987; 11(11):1181-91. DOI: 10.1111/j.1365-2559.1987.tb01858.x. View

2.
Ralfkiaer E, Pulford K, Lauritzen A, Avnstrom S, Guldhammer B, Mason D . Diagnosis of acute myeloid leukaemia with the use of monoclonal anti-neutrophil elastase (NP57) reactive with routinely processed biopsy samples. Histopathology. 1989; 14(6):637-43. DOI: 10.1111/j.1365-2559.1989.tb02205.x. View

3.
Ralfkiaer E, Saati T, Bosq J, Delsol G, Gatter K, Mason D . Immunocytochemical characterisation of cutaneous lymphomas other than mycosis fungoides. J Clin Pathol. 1986; 39(5):553-63. PMC: 499919. DOI: 10.1136/jcp.39.5.553. View

4.
Norton A, Isaacson P . Lymphoma phenotyping in formalin-fixed and paraffin wax-embedded tissues. I. Range of antibodies and staining patterns. Histopathology. 1989; 14(5):437-46. DOI: 10.1111/j.1365-2559.1989.tb02180.x. View

5.
Murphy G, Harrist T, Bhan A, Mihm Jr M . Distribution of cell surface antigens in histiocytosis X cells. Quantitative immunoelectron microscopy using monoclonal antibodies. Lab Invest. 1983; 48(1):90-7. View